<?xml version="1.0" encoding="UTF-8"?>
<p id="Par94">In line with these results, quality-of-life perception suggested trends toward symptomatic benefit. The SF-12 survey showed an improvement of the PCS throughout the follow-up period (
 <italic>p</italic> = 0.02) with a significant difference in the PCS at 12 months with respect to baseline (
 <italic>p</italic> ≤ 0.05). Both SF-12 MCS and MLHFQ total score did not change significantly during the follow-up period (Table 
 <xref rid="Tab4" ref-type="table">4</xref>).
</p>
